Carly Kenselaar

Stock Analyst at Citigroup

(3.14)
# 1,236
Out of 5,044 analysts
8
Total ratings
100%
Success rate
84%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Carly Kenselaar

Krystal Biotech
Jul 10, 2025
Maintains: Neutral
Price Target: $155$176
Current: $189.65
Upside: -7.20%
Travere Therapeutics
Jun 11, 2025
Maintains: Buy
Price Target: $35$32
Current: $29.81
Upside: +7.35%